Skip to main content
. 2026 Jan 28;21:520. doi: 10.1186/s13018-025-06639-6

Table 3.

Comorbidities of patients undergoing open reduction internal fixation (ORIF) or reverse shoulder arthroplasty (RSA)

ORIF RSA P value
AIDSa (%) 6(0.2%) 0(0%) 0.094
Alcohol abuse (%) 249(9.4%) 64(3.3%) < 0.001
Cardiac arrhythmias (%) 396(14.9%) 314(16.3%) 0.212
Cerebrovascular disease (%) 84(3.2%) 32(1.7%) 0.001
Chronic blood loss anemia (%) 29(1.1%) 22(1.1%) 0.880
Chronic pulmonary disease (%) 436(16.4%) 397(20.5%) < 0.001
Coagulopathy (%) 37(1.4%) 23(1.2%) 0.552
Congestive heart failure (%) 189(7.1%) 138(7.1%) 0.969
Deficiency anemia (%) 91(3.4%) 77(4.0%) 0.318
Dementia (%) 121(4.6%) 123(6.4%) 0.007
Depression (%) 380(14.3%) 313(16.2%) 0.076
Diabetes (uncomplicated) (%) 457(17.2%) 431(22.3%) < 0.001
Diabetes with chronic complication (%) 189(7.1%) 170(8.8%) 0.036
Drug abuse (%) 59(2.2%) 23(1.2%) 0.009
Fluid and electrolyte disorders (%) 560(21.1%) 329(17.0%) 0.001
Hypertension (%) 1,462(55.0%) 1,392(72.0%) < 0.001
Hypothyroidism (%) 354(13.3%) 390(20.2%) < 0.001
Leukemia (%) 6(0.2%) 10(0.5%) 0.098
Lymphoma (%) 5(0.2%) 4(0.2%) 0.887
Metastatic solid tumor (%) 12(0.5%) 6(0.3%) 0.450
Mild liver disease (%) 113(4.3%) 61(3.2%) 0.055
Moderate or severe liver disease (%) 19(0.7%) 13(0.7%) 0.865
Myocardial infarction (%) 110(4.1%) 80(4.1%) 0.999
Obesity (%) 422(15.9%) 381(19.7%) 0.001
Other neurological disorders (%) 314(11.8%) 131(6.8%) < 0.001
Paralysis (%) 12(0.5%) 3(0.2%) 0.082
Peptic ulcer disease (%) 13(0.5%) 5(0.3%) 0.217
Peripheral vascular disease (%) 67(2.5%) 47(2.4%) 0.848
Psychoses (%) 39(1.5%) 14(0.7%) 0.020
Pulmonary circulation disorders (%) 73(2.7%) 40(2.1%) 0.144
RA or CVb (%) 89(3.3%) 87(4.5%) 0.045
Renal disease (%) 207(7.8%) 222(11.5%) < 0.001
Solid tumor without metastasis (%) 34(1.3%) 31(1.6%) 0.358
Valvular disease (%) 105(4.0%) 97(5.0%) 0.081
Weight loss (%) 75(2.8%) 34(1.8%) 0.020

a: acquired immune deficiency syndrome. b: rheumatoid arthritis or collagen vascular diseases